Deadline in Lawsuit for Investors in Solid Biosciences Inc. (NASDAQ: SLDB) Shares Announced by Shareholders Foundation

SAN DIEGO, CA, April 2, 2018 (Newswire.com) - The Shareholders Foundation, Inc. announces that a deadline is coming up in the lawsuit that was filed for certain investors in NASDAQ: SLDB shares over alleged Securities Laws Violations by Solid Biosciences Inc.

Investors who purchased shares of Solid Biosciences Inc. (NASDAQ: SLDB) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.

On March 27, 2018, a lawsuit was filed against Solid Biosciences Inc over alleged violations of securities laws. The plaintiff claims that the defendants failed to disclose that Solid Biosciences' lead drug candidate SGT-001 had a high likelihood of causing adverse events in patients, that Solid Biosciences misled investors regarding the toxicity of SGT-001, and that, as a result of the foregoing, Defendants' statements in the Registration Statement regarding Solid Biosciences' business, operations, and prospects, were materially false and/or misleading

On January 30, 2018, an article was published by various medical experts highlighting the risks of studies using high doses of gene therapies using adeno-associated virus (AAV)-the delivery system used by Solid Biosciences' lead drug candidate SGT-001. One of the article's co-authors was Dr. James Wilson, a former member of the Solid Biosciences' advisory board.

On March 14, 2018, Solid Biosciences Inc. announced that its SGT-001 clinical trial had been put on hold by the Food and Drug Administration ("FDA") due to an adverse reaction to the treatment by one of the trial patients.

Those who purchased Solid Biosciences Inc. (NASDAQ: SLDB) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.

Source: Shareholders Foundation, Inc.